Baseline magnetic resonance imaging parameters and stroke outcome in patients treated by intravenous tissue plasminogen activator

被引:80
|
作者
Nighoghossian, N
Hermier, M
Adeleine, P
Derex, L
Dugor, JF
Philippeau, F
Ylmaz, H
Honnorat, J
Dardel, P
Berthezéne, Y
Froment, JC
Trouillas, P
机构
[1] Hop Neurol & Neurochirurg P Wertheimer, Biostat Unit, F-69003 Lyon, France
[2] CNRS, Cerebrovasc Dis Ctr, F-75700 Paris, France
[3] CNRS, Dept Radiol, F-75700 Paris, France
[4] CNRS, Creatis UMR 5515, F-75700 Paris, France
关键词
magnetic resonance imaging; diffusion-weighted magnetic resonance imaging; perfusion-weighted; stroke outcome; tissue plasminogen activator;
D O I
10.1161/01.STR.0000053850.64877.AF
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose-We designed a prospective sequential pretreatment and posttreatment MRI study to assess the relation between neuroimaging parameters and clinical outcome in patients treated with intravenous recombinant tissue-type plasminogen activator (rtPA). Methods-Patients with symptoms of acute hemispheric ischemic stroke were recruited. The National Institutes of Health Stroke Scale (NIHSS) score was assessed at baseline and at days 1, 7, and 60, and the modified Rankin scale (mRS) at day 60, by which outcome was classified in terms of independence (mRS score 0, 1, or 2) or severe disability or death (mRS score 3 through 6), was assigned. Multimodal stroke MRI was performed at presentation and repeated at day 1. MRI procedures included magnetic resonance angiography, T2* gradient-echo sequence, echoplanar imaging, and isotropic diffusion- (DWI) and perfusion-weighted (PWI) imaging. Patients were treated with intravenous rtPA after MRI completion. Results-Twenty-nine patients (16 men and 13 women; mean+/-SD age, 65+/-14 years) underwent MRI; the mean time from symptom onset to treatment was 255 62 minutes. Twenty-six patients had a vessel occlusion, and 15 patients experienced a partial (Thrombolysis in Myocardial Infarction [TIMI]-2) or total (TIMI-3) recanalization at day 1, whereas 11 patients had a persistent occlusion. Mean NIHSS scores at day 60 were 5.7+/-5.4 if recanalization had occurred and 14+/-2 in cases of persistent occlusion. According to the mRS, 13 patients were independent (mRS 0 through 2), whereas severe disability or death (mRS 3 through 6) was observed in 15 patients. A better outcome was observed when recanalization was achieved (r= -0.68, P=0.0002). PWI volume and time to peak (TTP) within the DWI lesion assessed before therapy were correlated with day-60 NIHSS score (PWI volume: r=0.51, P=0.006, TTP: r=0.35, P=0.07). The day-0 DWI abnormality volume was well correlated with day-60 NIHSS score (r=0.58, P=0.001). Multiple regression linear analysis showed that 2 factors mainly influenced clinical outcome: (1) recanalization, with a high correlation with NIHSS score at day 60 (P=0.0001) and (2) day-0 DWI lesion volume, which is closely associated with day-60 NIHSS score (P=0.03). Conclusions-Baseline DWI volume and recanalization are the main factors influencing clinical outcome after rtPA for ischemic stroke.
引用
收藏
页码:458 / 463
页数:6
相关论文
共 50 条
  • [41] Intravenous tissue plasminogen activator for acute ischemic stroke in patients with renal dysfunction
    Wang, I-K
    Yen, T-H
    Chen, C-H
    Hsu, S-P
    Sun, Y.
    Lien, L-M
    Chang, W-L
    Lai, T-C
    Chen, P-L
    Chen, C-C
    Huang, P-H
    Lin, C-H
    Su, Y-C
    Lin, M-C
    Li, C-Y
    Sung, F-C
    Hsu, C. Y.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2021, 114 (12) : 848 - 856
  • [42] Atrial fibrillation predicts good functional outcome following intravenous tissue plasminogen activator in patients with severe stroke
    Sung, Sheng-Feng
    Chen, Yu-Wei
    Tseng, Mei-Chiun
    Ong, Cheung-Ter
    Lin, Huey-Juan
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2013, 115 (07) : 892 - 895
  • [43] PREHOSPITAL STROKE MEDICAL ACTIVATION: IMPACT ON TIMES RESPONSE AND OUTCOME IN PATIENTS WITH ISCHEMIC STROKE TREATED WITH INTRAVENOUS RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR. PRELIMINARY DATA
    Bacelar, N.
    Martinez, M.
    Canovas, D.
    Carvajal, A.
    INTENSIVE CARE MEDICINE, 2009, 35 : 138 - 138
  • [44] Hyperdense middle cerebral artery sign and neurological recovery in intravenous tissue plasminogen activator treated stroke patients
    Vaishnav, AG
    Sen, S
    Ibrahim, M
    Verro, P
    NEUROLOGY, 1999, 52 (06) : A537 - A538
  • [45] Uric acid therapy improves the outcomes of stroke patients treated with intravenous tissue plasminogen activator and mechanical thrombectomy
    Chamorro, Angel
    Amaro, Sergio
    Castellanos, Mar
    Gomis, Meritxell
    Urra, Xabier
    Blasco, Jordi
    Arenillas, Juan F.
    Roman, Luis S.
    Munoz, Roberto
    Macho, Juan
    Canovas, David
    Marti-Fabregas, Joan
    Leira, Enrique C.
    Planas, Anna M.
    INTERNATIONAL JOURNAL OF STROKE, 2017, 12 (04) : 377 - 382
  • [46] Early Recanalization by Magnetic Resonance Imaging Identifies Patients with Large Vessel Occlusion Likely to Respond to Standard Intravenous Tissue Plasminogen Activator
    Hsia, Amie W.
    Lee, Kyung-Yul
    Latour, Lawrence L.
    Warach, Steven
    Merino, Jose G.
    Kidwell, Chelsea S.
    STROKE, 2009, 40 (04) : E159 - E160
  • [47] Determinants of Functional Outcomes in Patients Treated With Intravenous Tissue Plasminogen Activator in Telestroke
    Girotra, Tarun
    Ajinkya, Shaun
    Kohli, Disha
    Debenham, Ellen
    Holmstedt, Christine
    Banerjee, Chirantan
    STROKE, 2018, 49
  • [48] Utilization of intravenous tissue plasminogen activator for acute ischemic stroke
    Katzan, IL
    Hammer, MD
    Hixson, ED
    Furlan, AJ
    Abou-Chebl, A
    Nadzam, DM
    ARCHIVES OF NEUROLOGY, 2004, 61 (03) : 346 - 350
  • [49] Rapid Neurological Recovery after Intravenous Tissue Plasminogen Activator in Stroke: Prognostic Factors and Outcome
    Machumpurath, Bejoy
    Davis, Stephen M.
    Yan, Bernard
    CEREBROVASCULAR DISEASES, 2011, 31 (03) : 278 - 283
  • [50] Intravenous Recombinant Tissue-Type Plasminogen Activator: Influence on Outcome in Anterior Circulation Ischemic Stroke Treated by Mechanical Thrombectomy
    Ferrigno, Marc
    Bricout, Nicolas
    Leys, Didier
    Estrade, Laurent
    Cordonnier, Charlotte
    Personnic, Thomas
    Kyheng, Maeva
    Henon, Hilde
    STROKE, 2018, 49 (06) : 1377 - 1385